Concomitant triptan and SSRI or SNRI use: What is the risk for serotonin syndrome?

被引：1
作者：
Evans, Randolph W.
机构：
来源：
HEADACHE | 2008年 / 48卷 / 04期
关键词：
D O I：
10.1111/j.1526-4610.2008.01067.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：639 / 640
页数：3
相关论文
共 9 条
  • [1] Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum
    Bonetto, N.
    Santelli, L.
    Battistin, L.
    Cagnin, A.
    [J]. CEPHALALGIA, 2007, 27 (12) : 1421 - 1423
  • [2] Evans Randolph W, 2007, MedGenMed, V9, P48
  • [3] Psychiatric comorbidity of migraine
    Hamelsky, Sandra W.
    Lipton, Richard B.
    [J]. HEADACHE, 2006, 46 (09): : 1327 - 1333
  • [4] The pathophysiology of serotonin toxicity in animals and humans - Implications for diagnosis and treatment
    Isbister, GK
    Buckley, NA
    [J]. CLINICAL NEUROPHARMACOLOGY, 2005, 28 (05) : 205 - 214
  • [5] Mackay FJ, 1999, BRIT J GEN PRACT, V49, P871
  • [6] Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study
    Putnam, GP
    O'Quinn, S
    Bolden-Watson, CP
    Davis, RL
    Gutterman, DL
    Fox, AW
    [J]. CEPHALALGIA, 1999, 19 (07) : 668 - 675
  • [7] Concomitant triptan and SSRI or SNRI use: A risk for serotonin syndrome
    Sclar, David A.
    Robison, Linda M.
    Skaer, Tracy L.
    [J]. HEADACHE, 2008, 48 (01): : 126 - 129
  • [8] The serotonin syndrome, triptans, and the potential for drug-drug interactions
    Shapiro, Robert E.
    Tepper, Stewart J.
    [J]. HEADACHE, 2007, 47 (02): : 266 - 269
  • [9] US Food and Drug Administration, 2006, INF HEALTHC PROF SEL
1